Some patients who receive heart valve implants develop dangerous blood clots, and researchers from the University of Waterloo contributed to an international collaboration that reduces the risk.
Aug 20, 2024
0
0
Platelets are circulating cell fragments known to clump up and form blood clots that stop bleeding in injured vessels. Cardiologists have long known that platelets can become "hyperreactive" to cause abnormal clotting that ...
Aug 20, 2024
0
39
UVA Health scientists seeking drugs that can trigger the regeneration of heart tissue after a heart attack say their efforts show promise and may lead to future treatment options.
Aug 19, 2024
0
1
Mayo Clinic researchers are using artificial intelligence (AI) with an advanced 3D body-volume scanner—originally developed for the clothing industry—to help doctors predict metabolic syndrome risk and severity. The combination ...
Aug 15, 2024
0
9
For years, the question of whether to take medication to lower high blood pressure had been partly answered by a tool that calculated someone's 10-year risk of having a heart attack or stroke.
Aug 13, 2024
0
0
New Cleveland Clinic research shows that consuming foods with erythritol, a popular artificial sweetener, increases the risk of cardiovascular events such as heart attack and stroke. The findings, from a new intervention ...
Aug 8, 2024
0
74
UNSW researchers have developed a new microgel made of moth silk that is designed to assist with tissue regeneration and could help people recover from heart attacks.
Aug 7, 2024
0
3
Nearly 100 wildfires are currently raging throughout the country, burning more than 2 million acres. The rising frequency of these fires poses a special concern for anesthesiologists—the potential for increased rates of ...
Aug 6, 2024
0
0
Nicholas A. Marston, MD, MPH, of the TIMI Study Group and Carl J. and Ruth Shapiro Cardiovascular Center at Brigham and Women's Hospital, is the corresponding author of a paper published in Nature Medicine, "Clonal hematopoiesis, ...
Aug 6, 2024
0
0
Scientists at Nagoya University in Japan have made a significant breakthrough in treating lipid disorders. They have developed a new compound, ZTA-261, which selectively binds to the thyroid hormone receptor beta (THRβ).
Aug 6, 2024
0
26
